Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

From Genetic Testing to Prevention: An Integrated Clinical Pathway for Hereditary Risk Assessment in Tubo-Ovarian Cancer

1 Aug 2026

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Ovarian cancer diagnosis and treatment
Share to PARP inhibition in cancer therapy

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 42617415
DOI: 10.1016/j.ijgc.2026.104898

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

From Genetic Testing to Prevention: An Integrated Clinical Pathway for Hereditary Risk Assessment in Tubo-Ovarian CancerPMID 42617415Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.Semantic proximity Read ↗

Contemporary risk assessment and risk-reducing strategies for tubo-ovarian cancer in women with BRCA pathogenic variants.Semantic proximity Read ↗

NSGC Practice Guideline: Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian CancerSemantic proximity Read ↗

Risk assessment & genetic testing.Semantic proximity Read ↗

Genetic risk assessment in breast and gynecologic malignancies- what's to know in 2024?Semantic proximity Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.Semantic proximity Read ↗

Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics.Semantic proximity Read ↗

Risk assessment and genetic testing for ovarian cancer.Semantic proximity Read ↗

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.Semantic proximity Read ↗

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.Semantic proximity Read ↗

Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.Semantic proximity Read ↗

Development of genetic testing for breast, ovarian and colorectal cancer predisposition: a step closer to targeted cancer prevention.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.